Although the average of tumor volumes was reduced in mice receiving vaccination with irradiated B16F10 tumor cells plus anti-PD-1 antibody compared those treated with anti-PD-1 antibody alone, the difference did not reach statistical significance at any time point (Fig. 8b ).
← all excerpts
Vaccination with CD47 deficient tumor cells elicits an antitumor immune response in mice.
1
—
—